Setting the Pace for What's to Come

Image of Aveir VR Leadless Pacemaker on top of a gradient background


Long Term Retrieval Helix VR

AVEIR™ VR Leadless Pacemaker’s (LP) helical fixation is designed for
long-term retrieval, expanding
therapeutic options.1,2*


Battery Power

Battery has up to twice the capacity of other leadless pacemakers on the market.1,3

Mapping Prior to Fixation


AVEIR™ VR LP's mapping capability is designed to help reduce the number of repositioning attempts.1,4

Download the Physician Brochure to see all the AVEIR VR LP has to offer

Life-Changing Innovation

Dual Chamber System Upgradeability

Should new pacing indications present, the software for AVEIR VR Ventricular LP is designed to pair with AVEIR™ AR Atrial LP, allowing the devices to upgrade to an AVEIR™ DR Dual Chamber Leadless Pacemaker System.1**

outline of heart

AVEIR VR LP is 1.5T and 3T MR Conditional

AVEIR VR LP is MR Conditional for full-body scans using a 1.5T or 3T field strength MRI scanner.***

MR triangle
Life-changing innovation

See the innovations behind AVEIR VR LP 

View the Clinical Study


*The AVEIR VR Leadless Pacemaker’s predicate device has a overall long-term retrieval success rate above 88% with helix fixation with up to 9 years of retrieval experience. AVEIR VR LP is designed for long-term retrieval. Limited data is available for the AVEIR VR LP.2
** AVEIR AR Atrial LP System and AVEIR DR Dual Chamber LP Systems are commercially approved for use only in the USA market at this time. The AVEIR AR and AVEIR DR systems are currently under review and pending CE mark.
*** Stability of pacing capture thresholds is required prior to MRI scan. For additional information about specific MR Conditional, including warnings, precautions, adverse conditions to MRI scanning, and potential adverse events, please refer to the MRI-Ready Leadless Systems Manual at or check our MRI-Ready resources at

  1. AVEIR™ VR Leadless Pacemaker and Delivery Catheter IFU. ARTEN600175957.
  2. Reddy, VY, et al. Worldwide Experience with Leadless Pacemaker Retrievals at 9 years. Presented at 15th Asia Pacific Heart Rhythm Society (APHRS) Scientific Session; Nov 18-20, 2022; Singapore.
  3. Micra‡ VR IFU M991010A001 REV. B.
  4. Reddy, VY et al. Primary Results on Safety and Ecacy from the LEADLESS II-Phase 2 Worldwide Clinical Trial, JACC: Clinical Electrophysiology, 2021, ISSN2405-500X,

MAT-2310177 v2.0 | Item approved for global use. Product not approved in all geographies.